AAAAAA
Results:
1-19
|
Results: 19
Authors:
Lester, EP
Petroni, GR
Barcos, M
Johnson, JL
Millard, FE
Cooper, MR
Omura, GA
Frei, E
Peterson, BA
Citation: Ep. Lester et al., Cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) for advanced-stage Hodgkin's disease: CALGB 8856, CANCER INV, 19(5), 2001, pp. 447-458
Authors:
Lee, EJ
Petroni, GR
Schiffer, CA
Freter, CE
Johnson, JL
Barcos, M
Frizzera, G
Bloomfield, CD
Peterson, BA
Citation: Ej. Lee et al., Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: Results of cancer and leukemia group B study 9251, J CL ONCOL, 19(20), 2001, pp. 4014-4022
Authors:
Bissonette, EA
Fulmer, BR
Petroni, GR
Moul, JW
Theodorescu, D
Citation: Ea. Bissonette et al., Prostate specific antigen kinetics at tumor recurrence after radical prostatectomy do not suggest a worse disease prognosis in black men, J UROL, 166(4), 2001, pp. 1328-1331
Authors:
Santen, RJ
Pinkerton, J
McCartney, C
Petroni, GR
Citation: Rj. Santen et al., Clinical review 121 - Risk of breast cancer with progestins in combinationwith estrogen as hormone replacement therapy, J CLIN END, 86(1), 2001, pp. 16-23
Authors:
El-Rifai, W
Frierson, HF
Moskaluk, CA
Harper, JC
Petroni, GR
Bissonette, EA
Jones, DR
Knuutila, S
Powell, SM
Citation: W. El-rifai et al., Genetic differences between adenocarcinomas arising in Barrett's esophagusand gastric mucosa, GASTROENTY, 121(3), 2001, pp. 592-598
Authors:
Santen, RJ
Petroni, GR
Fisch, MJ
Myers, CE
Theodorescu, D
Cohen, RB
Citation: Rj. Santen et al., Use of the aromatase inhibitor anastrozole in the treatment of patients with advanced prostate carcinoma, CANCER, 92(8), 2001, pp. 2095-2101
Authors:
Bartlett, NL
Petroni, GR
Parker, BA
Wagner, ND
Gockerman, JP
Omura, GA
Canellos, GP
Cooper, MR
Johnson, JL
Peterson, BA
Citation: Nl. Bartlett et al., Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, andetoposide (CHOPE) chemotherapy for patients with diffuse lymphoma - Cancerand Leukemia Group B Studies 8852 and 8854, CANCER, 92(2), 2001, pp. 207-217
Authors:
Fulmer, BR
Bissonette, EA
Petroni, GR
Theodorescu, D
Citation: Br. Fulmer et al., Prospective assessment of voiding and sexual function after traetment for localized prostate carcinoma - Comparison of radical prostatectomy to hormonobrachytherapy with and without external beam radiotherapy, CANCER, 91(11), 2001, pp. 2046-2055
Authors:
Petroni, GR
Conaway, MR
Citation: Gr. Petroni et Mr. Conaway, Designs based on toxicity and response, HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY, 2001, pp. 105-118
Authors:
Krupski, T
Petroni, GR
Bissonette, EA
Theodorescu, D
Citation: T. Krupski et al., Quality-of-life comparison of radical prostatectomy and interstitial brachy-therapy in the treatment of clinically localized prostate cancer, UROLOGY, 55(5), 2000, pp. 736-742
Authors:
Krupski, T
Petroni, GR
Frierson, HF
Theodorescu, D
Citation: T. Krupski et al., Microvessel density, p53, retinoblastoma, and chromogranin a immunohistochemistry as predictors of disease-specific survival following radical prostatectomy for carcinoma of the prostate, UROLOGY, 55(5), 2000, pp. 743-749
Authors:
Gardner, TA
Bissonette, EA
Petroni, GR
McClain, R
Sokoloff, MH
Theodorescu, D
Citation: Ta. Gardner et al., Surgical and postoperative factors affecting length of hospital stay afterradical prostatectomy, CANCER, 89(2), 2000, pp. 424-430
Authors:
Krupski, T
Petroni, GR
Bissonette, EA
Theodorescu, D
Citation: T. Krupski et al., Quality of life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer, PROSTATE C, 2, 1999, pp. S32-S32
Urinary function after radical prostatectomy: A comparison of the retropubic and perineal approaches
Authors:
Gray, M
Petroni, GR
Theodorescu, D
Citation: M. Gray et al., Urinary function after radical prostatectomy: A comparison of the retropubic and perineal approaches, UROLOGY, 53(5), 1999, pp. 881-890
Authors:
Santen, RJ
Petroni, GR
Citation: Rj. Santen et Gr. Petroni, Relative versus attributable risk of breast cancer from estrogen replacement therapy, J CLIN END, 84(6), 1999, pp. 1875-1881
Authors:
Yustein, AS
Harper, JC
Petroni, GR
Cummings, OW
Moskaluk, CA
Powell, SM
Citation: As. Yustein et al., Allelotype of gastric adenocarcinoma, CANCER RES, 59(7), 1999, pp. 1437-1441
Authors:
Gioeli, D
Mandell, JW
Petroni, GR
Frierson, HF
Weber, MJ
Citation: D. Gioeli et al., Activation of mitogen-activated protein kinase associated with prostate cancer progression, CANCER RES, 59(2), 1999, pp. 279-284
Authors:
Wasserman, TH
Petroni, GR
Millard, FE
Chung, CT
Barcos, M
Johnson, JL
Canellos, GP
Peterson, BA
Citation: Th. Wasserman et al., Sequential chemotherapy (etoposide, vinblastine, and doxorubicin) and subtotal lymph node radiation for patients with localized Hodgkin disease and unfavorable prognostic features - A phase II Cancer and Leukemia Group B study (9051), CANCER, 86(8), 1999, pp. 1590-1595
Authors:
Halling, KC
Harper, J
Moskaluk, CA
Thibodeau, SN
Petroni, GR
Yustein, AS
Tosi, P
Minacci, C
Roviello, F
Piva, P
Hamilton, SR
Jackson, CE
Powell, SM
Citation: Kc. Halling et al., Origin of microsatellite instability in gastric cancer, AM J PATH, 155(1), 1999, pp. 205-211
Risultati:
1-19
|